Trials and tribulations: Oncological antibody imaging comes to the fore

Seminars in Nuclear Medicine

Volumn 27, Issue 1, 1997, Pages 10-29

  Zuckier, L S ^a   DeNardo, G L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY;

ANTIBODY LABELING; COLORECTAL CARCINOMA; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN CELL; IMAGE QUALITY; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOSCINTIGRAPHY; LUNG CARCINOMA; LYMPHOMA; OVARY CARCINOMA; PROSTATE CARCINOMA; RADIODIAGNOSIS; REVIEW;

EID: 0030948131     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(97)80033-5     Document Type: Article

References (180)

1. Pressman D Korngold L The in vivo localization of anti-Wagner-Osteogenic sarcoma antibodies Cancer 6 1953 619 623
2. (suppl) Larson SM Clinical radioimmunodetection, 1978–1988: Overview and suggestions for standardization of clinical trials Cancer Res 50 1990 892s 898s
3. Goldenberg DM Larson SM Radioimmunodetection in cancer identification J Nucl Med 33 1992 803 814
4. (suppl) Siccardi AG Buraggi GL Callegaro L Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma Cancer Res 46 1986 4817 4822
5. 2 fragments of an anti-carcinoembryonic monoclonal antibody: A multicenter study Cancer Res 49 1989 3095 3103
6. Siccardi AG Buraggi GL Natali PG European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments Eur J Nucl Med 16 1990 317 323
7. DeNardo GL Role of imaging in radioimmunotherapy Haseman MK The American College of Nuclear Physicians 1991 69 93
8. Delaloye AB Delaloye B Tumor imaging with monoclonal antibodies Semin Nucl Med 25 1995 144 164
9. Welt S Divgi CR Kemeny N Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer J Clin Oncol 12 1994 1561 1571
10. Kostakoglu L Divgi CR Hilton S Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49 Cancer Investigation 12 1994 551 558
11. Cheung NK Kushner BH Yeh SJ 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study Prog Clin Biological Res 385 1994 319 328
12. D2 in human brain tumors Eur J Nucl Med 22 1995 419 426
13. Food and Drug Administration Center for Biologics Evaluation and Research Office of Communication Training and Manufaeturers Assistance Sunmary of the approval process for a biological product 1996
14. Bogard WC Jr Dean RT Deo Y Practical consideration in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy Semin Nucl Med 19 1989 202 220
15. Swanson DP Radiopharmaceuticals as orphan drugs Semin Nucl Med 26 1996 91 95
16. F-D-C Reports Inc The NDA pipeline—1995 14th ed. 1996 F-D-C Reports Inc Chevy Chase, Maryland
17. Goldenberg DM Monoclonal antibody products: New advances J Biotechnology Healthcare 2 1996 412 422
18. Rotman M Laven D Levine G Radiopharmaceutical regulation and Food and Drug Administration policy Semin Nucl Med 26 1996 96 106
19. Goldenberg DM Goldenberg H Sharkey RM Imaging of colorectal carcinoma with radiolabeled antibodies Semin Nucl Med 19 1989 262 281
20. Beart RW Jr Colorectal cancer Holleb AI Fink DJ Murphy GP American Cancer Society Textbook of Clinical Oncology 1991 American Cancer Society Atlanta, GA 213 218
21. Johnson VG Schlom J Paterson AJ Analysis of a human tumor-associated glycoprotein (TAG-72) identified by a monoclonal antibody B72.3 Cancer Res 46 1986 850 857
22. Thor A Ohuchi N Szpak CA Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3 Cancer Res 46 1986 3118 3124
23. Rodwell JD Alvarez VL Lee C Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations Proc Natl Acad Sci 83 1986 2632 2636
24. Markowitz A Saleemi K Freeman LM Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma Clin Nucl Med 18 1993 685 700
25. Collier BD Abdel-Nabi H Doerr RJ Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: Comparison with CT Radiology 185 1992 179 186
26. Perkins AC Pimm MV Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. 1. The effect on image contrast in clinical studies Eur J Nucl Med 11 1985 295 299
27. (abstr) Shochat D Sharkey RM Vattay A In-111 chelated by DTPA-antibody is retained in the liver as a small molecular weight moiety J Nucl Med 27 1986 943
28. Doerr RJ Abdel-Nabi H Krag D Radiolabeled antibody imaging in the management of colorectal cancer Ann Surg 215 1991 118 124
29. 111In-CYT-103 scanning in recurrent colorectal cancer—does it affect standard management? Dis Colon Rectum 39 1996 514 519
30. Gold P Freedman SO Specific carcinoembryonic antigens of the human digestive system J Exp Med 122 1965 467 481
31. Primus FJ Newell KD Blue A Immunological heterogeneity of carcinoembryonic antigen: Antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies Cancer Res 43 1983 686 692
32. Moffat FL Jr Pinsky CM Hammershaimb L Clinical utility of external immunoscintigraphy with the IMMU-4 Technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal, phase III trial J Clin Oncol 14 1996 2295 2305
33. Hughes K, Pinsky CM, Petrelli NJ, et al: Use of carcinoembryonic antigen radioimmunodetection and computer tomography for predicting the resectability of recurrent colorectal cancer. Annals of Surgery, in press.
34. De Jager R Abdel-Nabi H Serafini A Current status of cancer immunodetection with radiolabeled human monoclonal antibodies Semin Nucl Med 23 1993 165 179
35. Moffat FL Jr Vargas-cuba R Serafini AN Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59 J Nucl Med 36 1995 738 745
36. (suppl) Gulec SA Serafini AN Moffat FL Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2 Cancer Res 55 1995 5774s 5776s
37. Herpst JM Correspondance September 9 1996
38. (abstr) Krause BJ Baum RP Staib-Sebler E Human monoclonal antibody Tc-99m-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment J Nucl Med 37 1996 9p
39. 111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcino-embryonic antigen levels and occult metastases J Clin Oncol 8 1990 1246 1254
40. Halpern SE Dillman RO Amox D Detection of occult tumor using Indium 111-labeled anticarcinoembryonic antigen antibodies Arch Surg 127 1992 1094 1100
41. Haseman MK Brown DW Kelling CA Radioimmunodetection of occult carcinoembryonic antigen-producing cancer J Nucl Med 33 1992 1750 1757
42. Thor AD Edgerton SM Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications Semin Nucl Med 19 1989 295 308
43. Adler DD Wahl RL New methods for imaging the breast: Techniques, findings, and potential AJR 164 1995 19 30
44. MacLean GD McEwan AJ Noujaim AA Two novel monoclonal antibodies have potential for gynecologic cancer imaging Antibody, Immunoconjug Radiopharm 4 1991 297 308
45. 111In Nucl Med Commun 1996
46. Sykes TR Woo TK Baum RP Direct labeling of monoclonal antibodies with technetium-99m by photoactivation J Nucl Med 36 1995 1913 1922
47. (abstr) Dessureault S Koven I Couture J Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous technetium-99m MAB-170 (Tru-Scint AD, Biomira, Inc): Preliminary results 18th Annual San Antonio Breast Cancer Symposium San Antonio, Texas 1995
48. 99mTc-labelled monoclonal antibody 170H.82 in breast cancer patients with no circulating antigen. 9th International Symposium on Radiopharmacology (abstr) The Quarterly Journal of Nuclear Medicine 39 1995 36
49. (abstr) Lind P Gallowitsch HJ Gomez I Initial clinical results with technetium 99m 170H.82 (Tru-Scint AD) in patients with breast and lung carcinoma 9th Annual IRIST Meeting Velden, Austria 1995
50. Biomira Division of Clinical and Regulatory Affairs Synopsis of imaging efficacy Tc-99m MAb-170 in breast and gynaecological cancer 1996
51. Colcher D Hand PH Nuti M A spectrum of monoclonal antibodies reactive with human mammary tumor cells Proc Natl Acad Sci 78 1981 3199 3203
52. Lamki LM Buzdar AU Singletary SE Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study J Nucl Med 32 1991 1326 1332
53. Crippa F Agresto R Bombardieri E Preliminary results of pre-operative axillary radioimmunoscintigraphy with In-111 B72.3 in breast cancer Int J Oncol 6 1995 791 795
54. (abstr) Abdel-Nabi H Rosner D Erb D Evaluation of suspicious mammographic findings with CEA-Scan and correlation with histopathological results J Nucl Med 37 1996 238
55. (abstr) Erb D Fuchs L Abdel-Nabi H Region of interest analysis can differentiate between benign, pre-malignant, and malignant breast conditions 1996 Society of Nuclear Medicine Technologist Section
56. (abstr) Rosner D Abdel-Nabi H Panaro V Immunoscintigraphy may reduce the number of surgical biopsies in women with benign breast disease and indeterminate mammograms 1996 ASCO
57. (abstr) Gulec SA Serafini AN Sfakianakis GN CEA-Scan in diagnosis and staging of breast cancer Soc Nuc Med 37 1996 238
58. Kramer EL DeNardo SJ Liebes L Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody Advances in Experimental Medicine and Biology 353 1994 181 192
59. Kramer EL DeNardo SJ Liebes L Radioimmunolocalization of metstatic breast carcinoma using Indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: Phase 1 study J Nucl Med 34 1993 1067 1074
60. Kramer EL Liebes L Wasserheit C Localization of In-111 MX-DTPA humanized BrE-3 MAb in patients with advanced breast cancer J Nucl Med 37 1996 169
61. 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-Br-E-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial Cancer Res 55 1995 5921s 5924s
62. Neal CE Swenson LC Fanning J Monoclonal antibodies in ovarian and prostate cancer Semin Nucl Med 23 1993 114 126
63. 111In-CYT-103 immunoscintigraphy in ovarian cancer Gynecol Oncol 48 1993 285 292
64. 111In-CYT-103 in patients with ovarian cancer Maguire RT Van Nostrand D Diagnosis of colorectal and ovarian carcinoma 1992 Marcel Dekker New York 111 124
65. 111In-CYT-103 on the surgical management of patients with ovarian cancer Maguire RT Van Nostrand D Diagnosis of colorectal and ovarian carcinoma. Application of immunoscintigraphic technology New York 1992 Marcel Dekker 125 140
66. Abdel-Nabi H Marchetti D Erb D Imaging of ovarian carcinoma patients with Tc-99m-88BV59, a totally human monoclonal antibody J Nucl Med 37 1996 9p (abstr)
67. Alexander C Villena-Heinsen CE Trampert L Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences Eur J Nucl Med 22 1995 645 651
68. Poels LG Peters D van Megen Y Monoclonal antibody against human ovarian tumour associated antigens J Natl Cancer Inst 76 1986 781 787
69. 2 monoclonal antibody J Nucl Med 31 1990 1802 1810
70. Breitz HB Sullivan K Nelp WB Imaging lung cancer with radiolabeled antibodies Semin Nucl Med 23 1993 127 132
71. Vansant JP Johnson DH O'Donnell DM Staging lung carcinoma with a Tc-99m labeled monoclonal antibody Clin Nucl Med 17 1992 431 438
72. Rusch V Macapinlac H Heelan R NR-LU-10 monoclonal antibody scanning. A helpful new adjunct to computed tomography in evaluating non-small-cell lung cancer J Thorac Cardiovasc Surg 106 1993 200 204
73. Kasina S Rao TN Srinivasan A Development and biological evaluation of a kit for preformed chelate. Tc-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent J Nucl Med 32 1991 1445 1451
74. Seattle, WA NeoRx Corporation Press release. FDA licenses Verluma, small cell lung cancer imaging kit August 20, 1996
75. Kramer EL Noz ME CT-SPECT fusion for analysis of radiolabeled antibodies: applications in gastrointestinal and lung carcinoma Nucl Med Biol 18 1991 27 42
76. Weber DA Ivanovic M Correlative image registration Semin Nucl Med 24 1994 311 323
77. Friedman S Sullivan K Salk D Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies Hematol/Oncol Clin North Am 4 1990 1069 1978
78. (suppl) Kramer EL Noz ME Liebes L Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab′ fragment Cancer 73 1994 890 895
79. Babaian RJ Lamki LM Radioimmunoscintigraphy of prostate cancer Semin Nucl Med 19 1989 309 321
80. Abdel-Nabi H Wright GL Gulfo JV Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer Semin Urol 10 1992 45 54
81. Horoszewicz JS Kawinski E Murphy GP Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients Anticancer Res 7 1987 927 936
82. Burgers JK Hinkle GH Haseman MK Monoclonal antibody imaging of recurrent and metastatic prostate cancer Semin Urol 13 1995 102 112
83. Schellhammer PF Wright GL Jr Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers Urol Clin North Am 20 1993 597 606
84. Cytogen. Immunoscintigraphy of primary and recurrent prostate cancer 1996
85. 111indium-labeled monoclonal antibody CYT-356 J Urol 152 1994 1952 1955
86. 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence J Urol 152 1994 1490 1495
87. DeNardo GL The next generation of imaging and therapeutic agents for lymphoma and chronic lymphocytic leukemia New Perspectives in Cancer Diagnosis and Management 3 1995 76 83
88. Epstein AL Marder RJ Winter JN Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential Cancer Res 47 1987 830 840
89. 131I-Lym-1 Cancer Res 50 1990 1014s 1016s
90. 131I]anti-B1 (anti-CD20) antibody N Engl J Med 329 1993 459 465
91. Kaminski MS Zasadny KR Francis IR Iodine-131-anti-B1 radioimunotherapy for B-cell lymphoma J Clin Oncol 14 1996 1974 1981
92. Knox SJ Goris ML Trisler K Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma Clin Cancer Res 2 1996 457 470
93. Murthy S Sharkey RM Goldenberg DM Lymphoma imaging with a new technetium-99m labelled antibody, LL2 Eur J Nucl Med 19 1992 394 401
94. 99mTc-labeled LL2-Fab' (Anti-CD22) fragments in the staging of B-cell Non-Hodgkin's lymphoma Cancer Res 55 1995 5771s 5773s
95. (suppl) Juweid M Sharkey RM Markowitz A Treatment of non-hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody Cancer Res 55 1995 5899s 5907s
96. 99mTc-labeled LL2 monoclonal antibody fragment Cancer Res 55 1995 5764s 5770s
97. Beazley RM Cohn I Jr Tumors of the liver Holleb AI Fink DJ Murphy GP American Cancer Society Textbook of Clinical Oncology 1991 American Cancer Society Atlanta, GA 237 244
98. (abstr) Dresel S Zachoval R Kirsch CM Immunoscintigraphy with AFP-monoclonal-antibody—clinical preliminary results European Association of Nuclear Medicine Congress 1994
99. (abstr) Kasi LP Kim EE Diaz M Pharmacokinetic evaluation of Tc-99m anti-AFP Fab' in patients with germ cell tumors J Nucl med 35 1994 11p 12p
100. Pirofski L Casadevall A Rodriguez L Current state of the hybridoma technology J Clin Immunol 10 1990 5s 14s
101. Pirofski L-A Casadevall A Scharff MD Current state of hybridoma technology ASM News 58 1992 613 617
102. Kohler G Milstein C Continuous cultures of fused cells secreting antibodies of predefined specificity Nature 256 1975 295 297
103. Sharkey RM Goldenberg DM Goldenberg H Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans Cancer Res 50 1990 2823 2831
104. Schlom J Eggensperger D Colcher D Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates Cancer Res 52 1992 1067 1072
105. Zuckier LS Rodriguez LD Scharff MD Immunologic and pharmacologic concepts of monoclonal antibodies Semin Nucl Med 19 1989 166 186
106. Waldmann TA Strober W Metabolism of immunoglobulins Progr Allergy 13 1969 1 110
107. Neuberger MS Williams GT Fox RO Recombinant antibodies possessing novel effector functions Nature 312 1984 604 608
108. Winter G Milstein C Man-made antibodies Nature 349 1991 293 299
109. Morrison SL In vitro antibodies: Strategies for production and application Annu Rev Immunol 10 1992 239 265
110. Wright A Shin S-U Morrison SL Genetically engineered antibodies: Progress and prospects Critical Reviews in Immunology 12 1992 125 168
111. (suppl) Hand PH Kashmiri SVS Schlom J Potential for recombinant immunoglobulin constructs in the management of carcinoma Cancer 73 1994 1105 1113
112. Suresh MR Cuello AC Milstein C Bispecific monoclonal antibodies from hybrid hybridomas Methods Enzymol 121 1986 210 228
113. Fell HP Gayle MA Grosmaire L Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab') with specificity for carcinomas and human IL-2 J Immun 146 1991 2446 2452
114. Shin S-U Morrison SL Expression and characterization of an antibody binding specificity joined to insulin-like growth factor I: Potential applications for cellular targeting Proc Natl Acad Sci 87 1990 5322 5326
115. Shin S-U Friden P Moran M Transferrinantibody fusion proteins are effective in brain targeting Proc Natl Acad Sci 92 1995 2820 2824
116. James K Bell GT Human monoclonal antibody production: Current status and future prospects J Immunol Methods 100 1987 5 40
117. James K Human monoclonal antibodies and engineered antibodies in the management of cancer Semin Cancer Biol 1 1990 243 253
118. Morrison SL Johnson MJ Herzenberg LA Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains Proc Natl Acad Sci 81 1984 6851 6855
119. Morrison SL Generations of human monoclonal antibodies reactive with cellular antigens Science 229 1985 1202 1207
120. Bruggemann M Williams GT Bindon CI Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies J Exp Med 166 1987 1351 1361
121. Bruggemann M Winter G Waldmann H The immunogenicity of chimeric antibodies J Exp Med 170 1989 2153 2157
122. Jones PT Dear PH Foote J Replacing the complementarity-determining regions in a human antibody with those from a mouse Nature 321 1986 522 525
123. Reichmann L Clark M Waldmann H Reshaping human antibodies for therapy Nature 332 1988 323 327
124. Verhoeyen M Milstein C Winter G Reshaping human antibodies: Grafting an antilysozyme activity Science 239 1988 1534 1536
125. Queen C Schneider WP Selick HE A humanized antibody that binds to the interleukin 2 receptor Proc Natl Acad Sci 86 1989 10029 10033
126. Roberts S Cheetham JC Rees AR Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering Nature 328 1987 731 734
127. Co MS Queen C Humanized antibodies for therapy Nature 351 1991 501 502
128. Steinitz M Klein G Koskimies S EB virus-induced B lymphocytic cell lines producing specific antibody Nature 269 1977 420 422
129. Nakamura M Burastero SE Ueki Y Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus J Immun 141 1988 4165 4172
130. Kozbor D Lagarde AE Roder JC Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines Proc Natl Acad Sci 79 1982 6651 6655
131. Ostberg L Pursch E Human X (mouse X human) hybridomas stably producing human antibodies Hybridoma 2 1983 361 367
132. Cote RJ Morrissey DM Houghton AN Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens Proc Natl Acad Sci 83 1986 2959 2963
133. Harding FA Lonberg N Class switching in human immunoglobulin transgenic mice Ann NY Acad Sci 764 1995 536 546
134. Jakobovits A Production of fully human antibodies by transgenic mice Curr Opin Biotechnol 6 1995 561 566
135. Bruggermann M Neuberger MS Strategies for expressing human antibody repertoires in transgenic mice Immunology Today 17 1996 391 396
136. 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy J Clin Invest 72 1983 2101 2114
137. Parham P On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice J Immunol 131 1983 2895 2902
138. 2 J Nucl Med 24 1983 316 325
139. Surtherland R Buchegger F Schreyer M Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids Cancer Res 47 1987 1627 1633
140. Bird RE Hardman KD Jacobson JW Single-chain antigen-binding proteins Science 242 1988 423 426
141. Milenic DE Yokota T Filpula DR Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49 Cancer Res 51 1991 6363 6371
142. Huston JS Levinson D Mudgett-Hunter M Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli Proc Natl Acad Sci 85 1988 5879 5883
143. Schlom J New approaches to improved antibody targeting Antibody, Immunoconjug Radiopharm 4 1991 819 828
144. Ward ES Gussow D Griffiths AD Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli Nature 341 1989 544 546
145. Williams WV, Moss DA, Kieber-Emmons T, et al: Development of biologically active peptides based on antibody structure. Proc Natl Acad Sci 5537:5541, 8696
146. Taub R Gould RJ Garsky VM A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibronogen J Biol Chem 264 1989 259 265
147. Knight LC Radcliffe R Maurer AH Thrombus imaging with technetium-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets J Nucl Med 35 1994 282 288
148. Sastry L Alting-Mees M Huse WD Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNA library Proc Natl Acad Sci 86 1989 5728 5732
149. Huse WD Sustry L Iverson SA Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda Science 246 1989 1275 1281
150. Wells JA Lowman HB Rapid evolution of peptide and protein binding properties in vitro Current Opinion in Biotechnology 3 1992 355 362
151. Pollock RR French DL Gefter ML Identification of mutant monoclonal antibodies with increased antigen binding Proc Natl Acad Sci 85 1988 2298 2302
152. Smith RIF Morrison SL Recombinant polymeric IgG: An approach to engineering more potent antibodies Bio/Technology 12 1994 683 688
153. Poon PH Morrison SL Schumaker VN Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b J Biol Chem 270 1995 8571 8577
154. Eckelman WC Paik CH Reba RC Radiolabeling of antibodies Cancer Res 40 1980 3036 3042
155. 131I-hippuran renal images Nucl Med Commun 8 1987 49 61
156. Fritzberg AR Wilbur DS Radiolabeling of antibodies for targeted diagnositics Torchilin VP Handbook of Targeted Delivery of Imaging Agent 1995 CRC Press Boca Raton, FL 83 101
157. Brechbiel MW Gansow OA Atcher RW Synthesis of 1-(p-isothiocyantobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies Inorganic Chemistry 25 1986 2772
158. Hnatowich DJ Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium Semin Nucl Med 20 1990 80 91
159. Kairemo KJ Positron emission tomography of monoclonal antibodies Acta Oncologica 32 1993 825 830
160. Philpott GW Schwartz SW Anderson CJ Radioi-imunoPET: detection of colorectal carcinoma with positronemitting copper-64-labeled monoclonal antibody J Nucl Med 36 1995 1818 1824
161. Sakahara H Endo K Koizumi M Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies J Nucl Med 29 1988 235 240
162. Andrew SM Johnstone RW Russell SM Comparison of in vitro cell binding characteristics of four monoclonal antibodies and their individual tumor localization properties in mice Cancer Res 50 1990 4423 4428
163. Sung C Shockley TR Morrison PF Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors Cancer Res 527 1992 377 384
164. Fujimori K Covell DG Fletcher JE A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier J Nucl Med 31 1990 1191 1198
165. Clark M Gilliland L Waldmann H Hybrid antibodies for therapy Progr Allergy 45 1988 31 49
166. Phelps JL Beidler DE Jue RA Expression and characterization of a chimeric bifunctional antibody with therapeutic applications J Immunol 145 1990 1200 1204
167. Moran TM Usuba O Shapiro E A novel technique for the production of hybrin antibodies J Immunol Methods 129 1990 199 205
168. Stickney DR Anderson LD Slater JB Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma Cancer Res 51 1991 6650 6655
169. LeDoussal J-M Chetanneau A Gruaz-Guyon A Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response J Nucl Med 34 1993 1662 1671
170. Peltier P Curtet C Chatal J-F Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/Anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer J Nucl Med 3467 1993 1267 1273
171. Paganelli G Magnani P Siccardi AG Clinical application of the avidin-biotin system for tumor targeting Goldenberg DM Cancer Therapy With Radiolabeled Antibodies 1995 CRC Press Boca Raton, FL 239 254
172. Paganelli G Malcovati M Fazio F Monoclonal antibody pretargetting techniques for tumour localization: the avidin-biotin system Nucl Med Commun 12 1991 211 234
173. Kalofonos HP Rusckowski M Siebecker DA Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication J Nucl Med 31 1990 1791 1796
174. Hnatowich DJ Virzi F Rusckowski M Investigations of avidin and biotin for imaging applications J Nucl Med 28 1987 1294 1302
175. Goodwin DA Tumor pretargeting: almost the bottom line J Nucl Med 36 1995 876 879
176. Guadagni F Roselli M Nieroda C Biological response modifiers as adjuvants in monoclonal antibody-based treatment in vivo 7 1993 591 600
177. LeBerthon B Khawli LA Alauddin M Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate Cancer Res 51 1991 2694 2698
178. Greiner JW Guadagni F Noguchi P Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo Science 235 1987 895 898
179. 131I-CC49) when given in combination with gamma-interferon Cancer Res 53 1993 600 608
180. Wahl RL Barrett J Geatti O The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage Cancer Immunol Immunother 26 1988 187 201